Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.133 | 68 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.15256 | 68 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.78816 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.80248 | 64 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.97039 | 66 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.15083 | 68 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.11728 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.01241 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.18604 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.11994 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.10559 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.30629 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.12102 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.0429 | 67 |